Acadia Healthcare Company Inc.'s stock soared 26.97% during intraday trading on Wednesday. The behavioral healthcare provider's shares surged following the release of its fourth-quarter and full-year 2025 financial results, which exceeded analyst expectations for both revenue and earnings per share.

The company reported adjusted earnings per share of $0.07 for the quarter, beating the consensus estimate of $0.06. Quarterly revenue reached $821.459 million, surpassing estimates of $800.065 million and representing a 6.1% year-over-year increase. While the company posted a significant net loss due to a non-cash goodwill impairment charge of approximately $996 million, investors focused on the underlying operational performance and growth metrics, including a 3.1% increase in patient days.

Acadia Healthcare also provided guidance for the first quarter and full fiscal year 2026, forecasting revenue and adjusted earnings within ranges that signaled continued operational growth. The positive market reaction was driven by the earnings beat, revenue growth, and the company's expansion through new facility openings and bed additions, overshadowing the one-time impairment charge and a noted future headwind from a Medicaid policy change.